ADACEL 2.5 MCG / 0.5 ML
PERTUSSIS TOXOID : 2.5 MCG / 0.5 ML FILAMENTOUS HAEMAGGLUTININ : 5 MCG / 0.5 ML DIPHTHERIA TOXOID : 2 LF / 0.5 ML PERTACTIN : 3 MCG / 0.5 ML FIMBRIAE TYPES 2 AND 3 (FIM) : 5 MCG / 0.5 ML TETANUS TOXOID : 5 LF / 0.5 ML · DIN 02240255 · SANOFI PASTEUR LIMITED
Health Canada status: MARKETED
What is ADACEL?
ADACEL 2.5 MCG / 0.5 ML contains PERTUSSIS TOXOID : 2.5 MCG / 0.5 ML FILAMENTOUS HAEMAGGLUTININ : 5 MCG / 0.5 ML DIPHTHERIA TOXOID : 2 LF / 0.5 ML PERTACTIN : 3 MCG / 0.5 ML FIMBRIAE TYPES 2 AND 3 (FIM) : 5 MCG / 0.5 ML TETANUS TOXOID : 5 LF / 0.5 ML. It is listed in the Health Canada Drug Product Database under DIN 02240255, held by SANOFI PASTEUR LIMITED, supplied as SUSPENSION for INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 27-Jul-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ADACEL used for?
Active booster immunization against tetanus, diphtheria, and pertussis in persons 4 years and older; vaccination during pregnancy for passive immunization of infants against pertussis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02240255 |
|---|---|
| Brand name | ADACEL |
| Generic / active ingredient | PERTUSSIS TOXOID : 2.5 MCG / 0.5 ML FILAMENTOUS HAEMAGGLUTININ : 5 MCG / 0.5 ML DIPHTHERIA TOXOID : 2 LF / 0.5 ML PERTACTIN : 3 MCG / 0.5 ML FIMBRIAE TYPES 2 AND 3 (FIM) : 5 MCG / 0.5 ML TETANUS TOXOID : 5 LF / 0.5 ML |
| Manufacturer | SANOFI PASTEUR LIMITED |
| Strength | 2.5 MCG / 0.5 ML |
| Dosage form | SUSPENSION |
| Route of administration | INTRAMUSCULAR |
| Schedule | Schedule D |
| ATC code | J07AJ52 PERTUSSIS, PURIFIED ANTIGEN, COMB. WITH TOXOIDS |
| AHFS class | 80:08.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 27-Jul-2006 |
| Original market date | 1999-06-23 00:00:00 |
How is it administered?
Single 0.5 mL dose via intramuscular injection, preferably in the deltoid muscle. Re-dosing can be used at 5- to 10-year intervals. Shake well before use.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
null
How is it supplied?
0.5 mL single dose glass vials (Type 1 glass). Available in packages of 1, 5, or 10 vials. Latex-free closure.
Contraindications
Hypersensitivity to any component; encephalopathy within 7 days of a previous pertussis-containing vaccine not attributable to another cause.
Warnings and precautions
Not for treatment of active infection. Postpone in acute/febrile disease. Risk of hematoma in patients with bleeding disorders. Potential for syncope and anaphylaxis.
What can be used instead?
Other Canadian products sharing ATC code J07AJ52 PERTUSSIS, PURIFIED ANTIGEN, COMB. WITH TOXOIDS. 1 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| TRI-IMMUNOL LIQ IM | 5 LF / 0.5 ML | LIQUID | LEDERLE LABS, DIVISION OF AMERICAN CYANAMID CO | CANCELLED POST MARKET | DIN 02019981 |
| TRIPACEL | 3 MCG / 0.5 ML | SUSPENSION | SANOFI PASTEUR LIMITED | APPROVED | DIN 02230273 |
| TRIPACEL HYBRID | 3 MCG / 0.5 ML | SUSPENSION | SANOFI PASTEUR LIMITED | CANCELLED POST MARKET | DIN 02224143 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.